Catégories
 > Thérapeutique > Thérapeutique médicamenteuse > Médicament
MédicamentSynonyme(s)Traitement Médication |
Documents disponibles dans cette catégorie (51)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : texte imprimé
Raynaud's phenomenon (RP) occurs in 3–5% of the population, with the rate of occurrence in women about four times that in men. It is caused by vasospasm of the blood vessels in the extremities, including the nipple. RP of the nipple can be extre[...]Article : texte imprimé
Drug treatment of RA need not be a barrier to breastfeeding; however, careful drug selection is important. Low-dose methotrexate is a mainstay of therapy, and limited data have found no indication of toxicity in breastfed infants, but more data [...]Article : texte imprimé
The Academy Breastfeeding Medicine (ABM) protocols have been accepted worldwide as the standard guide both for clinicians in how to manage the maternal–infant breastfeeding dyad and for the public health system in how to create a breastfeeding s[...]Article : texte imprimé
The plethora of new drugs to treat hepatitis presents a confusing array of options to treat the nursing mother. LactMed has recently undertaken an extensive review of these drugs to put them into a consistent context. [extrait de l'article]Article : texte imprimé
Discussion of medication use during breastfeeding usually centers around potential harm to the nursing infant. However, another important consideration is that of drugs that interfere with lactation. These can be divided into two subcategories: [...]Article : texte imprimé
This column discusses medications that affect lactation when given postpartum. The previous column discussed medications that affect the establishment of lactation when given before or during delivery. Additional details and literature reference[...]Article : texte imprimé
Chenxi Cai, Auteur ; Matthew Granger, Auteur ; Peter Eck, Auteur |Background: The literature on the iron requirements of exclusively breastfed infants contains conflicting data and contrary views. Objective: The purpose of this study was to summarize the evidence for both benefits and risks of daily oral ir[...]Article : texte imprimé
Yuka Wada, Auteur ; Fumio Suyama, Auteur ; Aiko Sasaki, Auteur ; Jumpei Saito, Auteur ; Yuika Shimizu, Auteur ; Shoichiro Amari, Auteur ; Yushi Ito, Auteur ; Haruhiko Sago, Auteur |Breast milk is the optimum for all infants, but hospitalization in the neonatal intensive care unit can cause separation of mothers and infants, which often interferes with milk secretion. Some reports show that domperidone is effective in promo[...]Article : texte imprimé
Jumpei Saito, Auteur ; Naho Yakuwa, Auteur ; Noriko Sandaiji, Auteur ; Hiroyo Kawasaki, Auteur ; Kayoko Kaneko, Auteur ; Tomo Suzuki, Auteur ; Akimasa Yamatani, Auteur ; Haruhiko Sago, Auteur ; Atsuko Murashima, Auteur |Background: Esomeprazole is the S-isomer of omeprazole and is used to treat stomach acid-related diseases. Most data regarding the safety of esomeprazole during pregnancy are derived from studies on omeprazole, and the data characterizing esomep[...]Article : texte imprimé
Lisa H. Amir, Auteur ; Luke E. Grzeskowiak, Auteur ; Renee Kam, Auteur |Key Messages Breastfeeding women often need to take medication, yet this population has been neglected by pharmaceutical companies and researchers. When using utilitarian ethical theory, with its foundational principle of utility, one should[...]Article : texte imprimé
Palika Datta, Auteur ; La Leche League France, Auteur |Article : texte imprimé
Gillian A. Beauchamp, Auteur ; Robert G. Hendrickson, Auteur ; Daniel A. Spyker, Auteur |Introduction: We described calls to U.S. poison centers (PCs) related to potential exposure to substances through breast milk. Materials and Methods: We analyzed National Poison Data System calls between 2001 and 2017 with “Exposure through b[...]texte imprimé
La prescription de produits pharmaceutiques chez la femme enceinte doit respecter la double règle qui veut que, d'une part, l'on privilégie la prise en charge de la future mère dont la vie est en danger plutôt que celle du foetus, et d'autre par[...]texte imprimé
This book is a practical guide for medical practitioners as they navigate through breastfeeding problems that occur in day-to-day practice. If mothers have a breastfeeding complication they are often directed to their GP. In complex situation[...]texte imprimé
"Written by a world-renowned expert in perinatal pharmacology, this essential reference contains current, complete, and evidence-based information on the transmission of maternal drugs into human milk. Because so many women ingest medications wh[...]Article : texte imprimé
Teresa Baker, Auteur ; Palika Datta, Auteur ; Kathleen Rewers-Felkins, Auteur |Background: Morbidly placenta accreta as a cause of postpartum morbidity is increasing in incidence. One conservative option is use of methotrexate as an adjuvant therapy for the management of placenta accreta. There is concern that use of metho[...]Article : texte imprimé
Adetola Louis-Jacques, Auteur ; Ronée Wilson, Auteur ; Kathryn Dean, Auteur ; Ivonne Hernandez, Auteur ; Diane L. Spatz, Auteur ; Sarah Obican, Auteur |Objectives: To improve maternal knowledge on medication and substance usage during lactation through prenatal breastfeeding education and assess breastfeeding rates at 2–4 and 6–8 weeks postpartum. Study Design: This quality improvement initi[...]Article : texte imprimé
Farhadi Roya, Auteur ; Philip Roy K., Auteur |One of the important challenges in surrogate pregnancies is the early bonding of genetic mother with her infant and the establishment of breastfeeding. A combination of pharmacological and nonpharmacological methods is often used for the inducti[...]Article : texte imprimé
Many Australian infants are being diagnosed as having 'reflux' based on symptoms alone, rather than on diagnostic tests. They are then prescribed medication. Research has clearly demonstrated that these medications are ineffective in infants and[...]Article : texte imprimé
Ahmadai Hila, Auteur ; Andrew Crowe, Auteur ; Lisa BG Tee, Auteur |Despite the known risks associated with opioid use during breastfeeding, their place in therapy is established as part of a multimodal approach to treatment of pain in the early postpartum period. Opioids may be prescribed for post-caesarean ana[...]Article : texte imprimé
Marta Krenz-Niedbala, Auteur ; Krzysztof Koscinski, Auteur ; Elzbieta A. Puch, Auteur |Background: Studies of the protective effect of breastfeeding on asthma have not brought unequivocal results, and thus this issue remains controversial. Antibiotic use, known to increase asthma risk, may be involved in this relationship. The obj[...]Article : texte imprimé
Laurence Spiesser Robelet, Auteur ; Vanida Brunie, Auteur ; Vincent de Andrade, Auteur |Background: Breastfeeding is a major public health issue in terms of its benefits to both mothers and infants. Despite recommendations, breastfeeding initiation and duration are low in many industrialized countries. Although human milk is viewe[...]Article : texte imprimé
Biologic medications are effective therapeutic options for treating autoimmune diseases, but information on their safety in lactation is still scarce. Autoimmune conditions occur frequently in women of childbearing age, creating difficult decisi[...]Article : texte imprimé
Lidocaine and bupivacaine have extensive documented use in nursing mothers and are the preferred injectable local anesthetics during breastfeeding. Topical anesthetics known to cause systemic toxicity after oral ingestion, such as benzocaine, co[...]Article : texte imprimé
Carine Issa, Auteur ; Maria Hobeika, Auteur ; Rouba Karen Zeidam, Auteur |This study aims to investigate the positive association between a longer duration of breastfeeding and better health outcomes from birth to 36 months by using direct health outcomes and indirect health indicators. It is a cross-sectional study i[...]
